These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26551065)

  • 21. 5'-Modified pyrimidine nucleosides as inhibitors of ribonuclease A.
    Samanta A; Dasgupta S; Pathak T
    Bioorg Med Chem; 2011 Apr; 19(7):2478-84. PubMed ID: 21420869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor.
    Iyer S; Holloway DE; Kumar K; Shapiro R; Acharya KR
    J Mol Biol; 2005 Apr; 347(3):637-55. PubMed ID: 15755456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses.
    Yang D; Chen Q; Su SB; Zhang P; Kurosaka K; Caspi RR; Michalek SM; Rosenberg HF; Zhang N; Oppenheim JJ
    J Exp Med; 2008 Jan; 205(1):79-90. PubMed ID: 18195069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of catalytic and non-catalytic subsite residues in ribonuclease activity of human eosinophil-derived neurotoxin.
    Sikriwal D; Seth D; Batra JK
    Biol Chem; 2009 Mar; 390(3):225-34. PubMed ID: 19090717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
    Cottin V; Deviller P; Tardy F; Cordier JF
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational analysis of the complex of human RNase inhibitor and human eosinophil-derived neurotoxin (RNase 2).
    Teufel DP; Kao RY; Acharya KR; Shapiro R
    Biochemistry; 2003 Feb; 42(6):1451-9. PubMed ID: 12578357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human eosinophil-derived neurotoxin: involvement of a putative non-catalytic phosphate-binding subsite in its catalysis.
    Sikriwal D; Seth D; Dey P; Batra JK
    Mol Cell Biochem; 2007 Sep; 303(1-2):175-81. PubMed ID: 17483910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystallographic and functional studies of a modified form of eosinophil-derived neurotoxin (EDN) with novel biological activities.
    Chang C; Newton DL; Rybak SM; Wlodawer A
    J Mol Biol; 2002 Mar; 317(1):119-30. PubMed ID: 11916383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboxymethylsulfonylated Ribopyrimidines: Rational Design of Ribonuclease A Inhibitors Employing Chemical Logic.
    Datta D; Dasgupta S; Pathak T
    ChemMedChem; 2016 Mar; 11(6):620-8. PubMed ID: 26945688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structures of eosinophil-derived neurotoxin (EDN) in complex with the inhibitors 5'-ATP, Ap3A, Ap4A, and Ap5A.
    Baker MD; Holloway DE; Swaminathan GJ; Acharya KR
    Biochemistry; 2006 Jan; 45(2):416-26. PubMed ID: 16401072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv.
    Newton DL; Nicholls PJ; Rybak SM; Youle RJ
    J Biol Chem; 1994 Oct; 269(43):26739-45. PubMed ID: 7929408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversity among the primate eosinophil-derived neurotoxin genes: a specific C-terminal sequence is necessary for enhanced ribonuclease activity.
    Rosenberg HF; Dyer KD
    Nucleic Acids Res; 1997 Sep; 25(17):3532-6. PubMed ID: 9254715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structures of ribonuclease A complexes with 5'-diphosphoadenosine 3'-phosphate and 5'-diphosphoadenosine 2'-phosphate at 1.7 A resolution.
    Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
    Biochemistry; 1997 May; 36(18):5578-88. PubMed ID: 9154942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction.
    Suzuki M; Saxena SK; Boix E; Prill RJ; Vasandani VM; Ladner JE; Sung C; Youle RJ
    Nat Biotechnol; 1999 Mar; 17(3):265-70. PubMed ID: 10096294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
    Pedersen B; Dahl R; Karlström R; Peterson CG; Venge P
    Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperglycosylation of eosinophil ribonucleases in a promyelocytic leukemia cell line and in differentiated peripheral blood progenitor cells.
    Tiffany HL; Li F; Rosenberg HF
    J Leukoc Biol; 1995 Jul; 58(1):49-54. PubMed ID: 7616105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells.
    Yang D; Rosenberg HF; Chen Q; Dyer KD; Kurosaka K; Oppenheim JJ
    Blood; 2003 Nov; 102(9):3396-403. PubMed ID: 12855582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis.
    Hamann KJ; Barker RL; Loegering DA; Gleich GJ
    J Parasitol; 1987 Jun; 73(3):523-9. PubMed ID: 3598802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative inhibitory activity of 3'- and 5'-functionalized nucleosides on ribonuclease A.
    Debnath J; Dasgupta S; Pathak T
    Bioorg Med Chem; 2010 Dec; 18(23):8257-63. PubMed ID: 21041096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological activity of certain 1,2,3-triazole carboxamide nucleosides related to bredinin and pyrazofurin.
    Revankar GR; Solan VC; Robins RK; Witkowski JT
    Nucleic Acids Symp Ser; 1981; (9):65-8. PubMed ID: 6117831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.